ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Cancer Act Pulled Entire NIH Budget Up, Schmidt Says

July 20, 1984

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992

Ralph Steinman Wins Nobel Prize Three Days After His Death

October 14, 2011

May issue of Business & Regulatory Report, 8 additional pages, included.

May 28, 2004

Funding Opportunities: Career Development Award In Leukemia

July 23, 1999

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009